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Visual Abstract
Significance Statement
Therapeutic methods for improving intellectual disability in Down syndrome (DS) are limited, and their outcome
remains unsatisfactory. Recently, we demonstrated that combined treatment with (-)-epigallocatechin-3-gallate
(EGCG) and cognitive stimulation rescued cognitive deficits in DS individuals in a phase II clinical trial and also in a
middle-age Ts65Dn mouse model of DS. Here, we show that environmental enrichment (EE) plus EGCG treatment
improves corticohippocampal-dependent learning and memory deficits in young trisomic mice, restores cornu
ammonis 1 (CA1) hippocampal dendritic spine density, and mitigates disruptions in excitatory/inhibitory synaptic
puncta inCA1anddentate gyrus.Our results suggest that therapieswith the capacity to simultaneously target several
abnormal processes underlying intellectual disability and use physiologic plasticity-enhancing interventions such as
EE are optimal for disease-modifying interventions.
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Intellectual disability in Down syndrome (DS) is accompanied by altered neuro-architecture, deficient synaptic
plasticity, and excitation-inhibition imbalance in critical brain regions for learning and memory. Recently, we have
demonstrated beneficial effects of a combined treatment with green tea extract containing (-)-epigallocatechin-
3-gallate (EGCG) and cognitive stimulation in young adult DS individuals. Although we could reproduce the
cognitive-enhancing effects in mouse models, the underlying mechanisms of these beneficial effects are
unknown. Here, we explored the effects of a combined therapy with environmental enrichment (EE) and EGCG in
the Ts65Dn mouse model of DS at young age. Our results show that combined EE-EGCG treatment improved
corticohippocampal-dependent learning and memory. Cognitive improvements were accompanied by a rescue of
cornu ammonis 1 (CA1) dendritic spine density and a normalization of the proportion of excitatory and inhibitory
synaptic markers in CA1 and dentate gyrus.
Key words: (-)-epigallocatechin-3-gallate; Down syndrome; environmental enrichment; excitation-inhibition im-
balance; neuroplasticity
Introduction
Down syndrome (DS) is the most common genetic form
of intellectual disability, with 10 in 10,000 and 14 in
10,000 live births in European countries (Khoshnood
et al., 2011) and the United States (Parker et al., 2010),
respectively. It arises from the presence of an extra copy
(or major portion) of chromosome 21 (Hsa21), leading to a
complex genetic imbalance (Antonarakis et al., 2004).
Individuals with DS show moderate to severe cognitive
impairment, with an average intellectual quotient of 40–50
(de Sola et al., 2015) and 39.4% in the mild intellectual
disability range of 50–70. The neuropsychological profile
is characterized by marked hippocampal-dependent def-
icits particularly affecting spatial learning, memory, and
executive functions, among other cognitive domains
(Chapman and Hesketh, 2000; Nadel, 2003; Pennington
et al., 2003). These cognitive deficits are associated with
distinct neuro-architectural, synaptic, and neurochemical
alterations (Lott and Dierssen, 2010; Dierssen, 2012). At
the cellular level, there is a reduction in dendritic number
and complexity in cortical and hippocampal neurons,
which affects synaptic connectivity (Becker et al., 1986).
Furthermore, accumulating evidence suggest that DS
pathophysiology is tightly associated with a disruption of
the balance between the excitatory and inhibitory neuro-
nal systems (Reynolds and Warner, 1988; Risser et al.,
1997; Seidl et al., 2001; Bhattacharyya et al., 2009). These
abnormalities are of particular importance because they
are related to disruptions in neural plasticity, which is
essential for cognition (Baroncelli et al., 2011).
Several research groups have shown that it is possible
to partially rescue DS phenotypes using nonpharmaco-
logical strategies such as postnatal handling or cognitive
training by environmental enrichment (EE) that ameliorate
behavioral and brain alterations in the Ts65Dn mouse
model of DS (Martínez-Cué et al., 2002; Dierssen, 2003;
Begenisic et al., 2011; Chakrabarti et al., 2011; Golabek
et al., 2011). It is widely accepted that EE is a cognitive
enhancing intervention that promotes synaptic plasticity,
adult neurogenesis, and epigenetic modifications, among
other processes (Sale et al., 2014). However, despite its
beneficial effects, EE is not sufficient to promote long-
lasting dendritic spine remodeling in Ts65Dn mice (Diers-
sen, 2003) or significant developmental changes in DS
children (Mahoney et al., 2004).
More recently, (-)-epigallocatechin-3-gallate (EGCG),
the most abundant catechin found in green tea, with
antioxidant and neuroprotective properties, has been
shown to efficiently improve cognitive phenotypes in DS
individuals and mouse models (De la Torre et al., 2014),
ameliorate synaptic plasticity impairment in vitro (Xie
et al., 2008), and restore excitatory/inhibitory (E/I) imbal-
ance in Ts65Dn mice (Souchet et al., 2015). EGCG is a
natural inhibitor of the kinase activity of Hsa21 candidate
gene Dyrk1A (Bain et al., 2003), whose overexpression is
sufficient to induce cognitive and neuromorphologic alter-
ations (Altafaj et al., 2001; Martinez de Lagran et al., 2012)
and that is also modulated by EE (Golabek et al., 2011;
Pons-Espinal et al., 2013). Recently, we showed that
combined treatment with EE and EGCG is more efficient
than EE or EGCG alone to ameliorate age-associated
cognitive impairment of older Ts65Dn mice (Catuara-
Solarz et al., 2015), suggesting a synergistic mechanism.
Furthermore, we demonstrated that combined treatment
with cognitive training and EGCG is more efficient than
cognitive training alone to promote cognitive enhance-
ment as well as neurophysiological recovery in young
adults with DS in a phase II clinical trial (de la Torre et al.,
2016). Thus, here we explored the effects of combined
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EE-EGCG treatment on hippocampal cognitive, neuronal,
and synaptic alterations in young adult Ts65Dn mice.
Materials and Methods
Animals
Ts65Dn (TS) and wild-type (WT) littermates were ob-
tained through crossings of B6EiC3Sn a/A-Ts(1716)65Dn
(Ts65Dn) females to B6C3F1/J males purchased from the
Jackson Laboratory (Bar Harbor, ME; RRID:IMSR_JAX:
001924). The mouse colony was bred in the Animal Fa-
cilities of the Barcelona Biomedical Research Park
(PRBB, Barcelona, Spain). Mice were housed in standard
or enriched conditions (see below) under a 12:12-h light:
dark schedule (lights on at 8:00 a.m.) in controlled envi-
ronmental conditions of humidity (60%) and temperature
(22°C  2°C) with ad libitum access to food and water.
Both the Ts65Dn and euploid mice were genotyped by
quantitative PCR, in accordance with the Jackson Labo-
ratory protocol.
Experiments were conducted using 1- to 2-month-old
female mice. We used females because in EE conditions,
Ts65Dn males show high levels of stress that could mask
the effect of the treatment (Martínez-Cué et al., 2002).
Although the estrus cycle may be slightly delayed in
Ts65Dn mice, by the age of 2 months it is synchronized
among all females (including Ts65Dn and euploid mice;
Netzer et al., 2010). Thus, for the experiments conducted
in this study, it is unlikely that variations in estrogen levels
between mice could influence behavior, spine density, or
E/I balance.
All animal procedures met the guidelines of European
Community Directive 2010/63/EU and local guidelines
(Real Decreto 53/2013) and were approved by the local
ethics committee (Comité Ético de Experimentación Ani-
mal del PRBB; procedure numbers MDS-08-1060P2 and
MDS-14-1611).
EE and EGCG
Ts65Dn and WT 1- to 2-month-old female mice were
assigned using a simple randomization to either control
conditions or a combination of EE and green tea extracts
containing 45% EGCG. Mice received the treatments for
30 days based on previous studies (De la Torre et al.,
2014; Catuara-Solarz et al., 2015). In the control condi-
tions, animals were reared in conventional Plexiglas cages
(20  12  12-cm height) in groups of 2–3 animals. EE
housing consisted of spacious (55  80  50-cm height)
cages with toys, small houses, tunnels, and platforms of
different shapes, sizes, colors, and textures. Wheels were
not introduced in the cages to avoid the effect of physical
exercise. The arrangement was changed every 2 days to
keep novelty conditions. To stimulate social interactions,
6–8 mice were housed in each cage. Green tea extract
containing 45% EGCGwas administered in drinking water
(EGCG dosage: 0.326 mg/ml, 0.65 mg per day; 30 mg/kg
per day) by preparing fresh EGCG solution every 2 days
from a green tea leaf extract (Mega Green Tea Extract,
Decaffeinated, Life Extension, Fort Lauderdale, FL; EGCG
content 326.25 mg per capsule).
Morris water maze
The Morris water maze (MWM) was performed accord-
ing to a previously described method (Catuara-Solarz
et al., 2015). Briefly, mice were trained in a water maze
(pool, 1.70-m diameter; platform, 12-cm diameter) during
five learning sessions (four acquisition trials per session
and one session per day). Twenty-four hours after the final
acquisition session, mice underwent one probe/removal
session (reference memory trial) in which the platform was
removed, followed by one cued session. Starting the next
day, three reversal sessions (four trials per session) were
conducted in which the platform position was changed
180° to test cognitive flexibility as a measure of executive
function. In every session, mice randomly entered the
pool from four different positions and were allowed to
search the platform for 60 s. The experimenter who per-
formed all the MWM procedures was blind to mice geno-
type. Mice were video-tracked during the test, and their
latency to reach the platform, total distance swum, time
spent in periphery, and swimming speed were recorded
using SMART software (Panlab, Barcelona, Spain, RRID:
SCR_002852). Subsequently, data were computed with
software developed by our lab (Jtracks; Arqué et al., 2008)
to obtain other measurements to quantify the most effi-
cient and direct trajectory from the location of mice to the
platform, such as the Gallagher index (average distance
from each mouse to the center of the platform), the Gal-
lagher distance (accumulated distance from each mouse
to the center of the platform), and the Whishaw index
(percentage of path inside the optimal corridor connecting
release site and goal; Whishaw and Jarrard, 1996). Mice
that did not reach the platform in30 s in the cue session
were considered unsuitable for the test and were sub-
tracted from the analysis. One overperforming mouse
from the EE-EGCG–treated TS group was removed from
the analysis. The estimate of the number of mice required
(n  10) was based on the expected difference between
the experimental groups, deriving from previous data ob-
tained in our laboratory (WT, n  11; TS, n  8; WT-EE-
EGCG, n  12; TS-EE-EGCG, n  8).
Novel object recognition test
The novel object recognition test was performed as an
adaptation from the protocols described in Leger et al.
(2013). The procedure was conducted in a V-maze appa-
ratus (wall height 27 cm, arm length 30 cm, and arm width
6 cm). First, mice were subjected to a 5-min habituation
session during which they were allowed to explore the
maze without any objects. The next day, mice went
through a 10-min familiarization session in which two
identical objects were situated at the end of each arm
attached to the wall and the floor with adhesive tape. After
a 60-min intertrial interval, the recognition test session
was conducted consisting of a 5-min trial in which one of
the objects used at familiarization was substituted by a
new object. Recognition of the new object was assessed
by calculating the discrimination index (DI) by the follow-
ing formula DI  (novel object exploration time/total ex-
ploration time) – (familiar object exploration time/total
exploration time) 100. Exploratory behavior was defined
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as the mouse directing its head or sniffing toward the
object at a distance of 1–2 cm. The estimate of the
sample size was based on previous data obtained in our
laboratory (WT, n  8; TS, n  7; WT-EE-EGCG, n  7;
TS-EE-EGCG, n  7).
Golgi neuronal staining and dendritic spine imaging
To avoid confounding effects, these experiments were
performed with mice that did not undergo behavioral
assessment. Golgi staining was performed according to
manufacturer instructions (SuperGolgi Kit, Bioenno Tech,
Santa Ana, CA; cat. # 003010, RRID:AB_2620135). Mice
were sacrificed with CO2 and perfused intracardially with
0.01 M PBS followed by chilled 4% paraformaldehyde
(PFA). Brains were removed from the skull and hemi-
spheres were immersed freshly into impregnation solution
for 9 days. When impregnation was ready, tissue blocks
were rinsed with distilled water and transferred into post-
impregnation buffer for 4–5 days at room temperature
(RT) in the dark. The solution was renewed after 1 day of
immersion. After that, brains were cut with a vibratome
(VT1000S; Leica Microsystems, Wetzlar, Germany) in sec-
tions of 150 m and kept in collection and mounting
buffer. Sections were mounted on adhesive microscope
slides, and gentle pressure was applied with filter paper
over the sections to enhance adhesion. Slides were
washed in 0.01 M PBS/0.3%Triton X-100 for 20–30 min
and placed in the staining solution for 20 min in a closed
dark jar. After that, slides were moved to the poststaining
buffer for 20 min in a dark area and washed in 0.01 M
PBS/0.3% Triton X-100 for 15 min. Slides were dried in a
closed jar at RT for 1 d. Finally, sections were dehydrated
in 100% ethanol for 5–10 min and cleared in xylene for
another 10 min. Slides were covered with coverslips using
mounting medium and were kept at RT in a dark area.
Images were acquired from outer molecular layer sec-
ondary apical dendrites of granule neurons (located
40–90 m from the neuronal soma) of the dentate gyrus
(DG) and secondary apical dendrites from pyramidal neu-
rons from the cornu ammonis 1 (CA1; located 50–100 m
from the neuronal soma). These hippocampal regions
were selected because they play a critical role in the
process and storage of spatial information (Tsien et al.,
1996; Deng et al., 2010). We used an Olympus BX51
microscope with 100 objective and Neurolucida soft-
ware (11.03.1, MBF Bioscience, Williston, VT; RRID:
SCR_001775). Quantification of dendritic spine density
was performed on 20-m dendritic segment lengths using
NIH ImageJ software version 1.46a and Multipoint plugin.
The criterion to define dendritic spines was the identifica-
tion of tridimensional protrusions emerging from the den-
dritic shaft that could be visualized across the z-planes.
For this experiment, we used three brain slices per mouse
of the dorsal hippocampus (bregma: 1.82–1.94, Paxinos
and Franklin, 2012) of five to six mice per experimental
group. From each brain slice, two to three dendrites from
each hippocampal subregion were imaged (number of
dendrites in DG: WT, 46; TS, 42; WT EE-EGCG, 48; TS
EE-EGCG, 42; number of dendrites in CA1: WT, 38; TS,
32; WT EE-EGCG, 31; TS EE-EGCG, 39).
Immunohistochemical labeling of excitatory and
inhibitory synaptic vesicle proteins
Synaptic modifications due to genotype and treatment
were addressed by performing immunohistochemical la-
beling for vesicular glutamate transporter 1 (VGLUT1) and
vesicular GABA transporter (VGAT). Animals were ex-
posed to CO2 and afterward perfused intracardially with
0.01 M PBS, pH 7.5, followed by 4% PFA. Brains were
removed, kept at 4°C in 4% PFA overnight, and trans-
ferred to a solution of 30% sucrose in PBS for 2 days.
Series of coronal sections (40 m) were obtained using a
vibratome (VT1000S; Leica Microsystems) and stored at
–20°C in a cryoprotection solution (30% ethylene glycol,
30% glycerol, 40% PBS). Free-floating brain sections
were permeabilized with 0.3% Triton X-100 in PBS for 30
min at RT and incubated for 20 min with Glycine (50 mM)
in PBS/0.3% Triton X-100. Slices were washed for 15 min
with PBS/0.3% Triton X-100 and blocked with 5% normal
goat serum (NGS)/PBS/-0.3% Triton X-100 for 1 h at RT.
Sections were incubated overnight at 4°C with the primary
antibodies—mouse anti-VGLUT1 monoclonal antibody (1:
150; cat. no. 135-511, Synaptic Systems, Goettingen,
Germany; RRID: AB_887879) and guinea pig anti-VGAT
polyclonal antibody (1:200; cytoplasmic domain; Synaptic
Systems; cat. no. 131004, RRID:AB_887873)—in 0.1%
Triton X-100/2.5% NGS in PBS. Slices were washed with
PBS/0.3% Triton X-100 and incubated with secondary
antibodies—Alexa Fluor 488 goat anti-mouse (cat. no.
A11001, RRID:AB_2534069) and Alexa Fluor 555 anti–
guinea pig (cat. no. A-21435, RRID:AB_2535856;
1:1000—in 0.1% Triton X-100/2.5% NGS in PBS for 2 h at
RT, protected from light. Finally, sections were washed
with PBS/0.3% Triton X-100, nuclei were stained with
Hoechst (1:1000) in PBS for 10 min, and tissues were
mounted on glass slides with Mowiol reagent.
Images were acquired from DG and CA1 hippocampal
regions using a confocal microscope with a 63 objective
(TCS SP5, Leica Microsystems) and LAS AF software. For
each region, all pictures were captured with identical
confocal settings for laser power, gain, and offset levels.
Images were imported into ImageJ, converted into binary
data, and thresholded to achieve maximum number of
individual puncta without causing puncta fusion. The
same threshold was applied to all the images to outline
puncta number, size, and percentage of area occupied by
puncta, using the “analyze particle” plugin. For this ex-
periment, we used two brain slices of the dorsal hip-
pocampus (bregma: 1.82–1.94, Paxinos and Franklin,
2012) of four mice per experimental group. From each





Differences among experimental groups over time were
tested using a single-variate analysis for selected
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learning-related parameters (latency to reach the plat-
form, Gallagher index, and percentage of time spent in the
periphery) using one-way repeated-measures ANOVA. To
avoid the ceiling effect of mice unable to solve the task,
the variable latency was considered right-censored when
reaching the maximum allowed time (60 s; Vock et al.,
2012) using a Tobit model implemented in the censReg
package from R Foundation for Statistical Computing
(RRID:SCR_001905), version 3.2.1 (Henningsen, 2011).
Multiple comparisons for parametric models were used to
address post hoc comparisons using the multtest R pack-
age and the glht function (Hand and Taylor, 1987; Dick-
haus, 2012). To control the FDR caused by multiple post
hoc comparisons, the Benjamini–Hochberg method was
used (Benjamini and Hochberg, 1995).
Principal component analysis
We used principal component analysis (PCA) to identify
the linear combinations of the original variables (latency to
reach the platform, percentage of time spent in target
quadrant, percentage of time spent in the periphery,
Whishaw index, Gallagher index, distance traveled, and
speed) that explain the maximum amount of experimental
variability. More precisely, our application of the method
aims primarily at two kinds of variability: variation among
experimental groups for a given learning session and
variation of a given group across learning sessions. For
this, we implemented the same procedure as described in
Catuara-Solarz et al. (2015). Briefly, a PCA for the acqui-
sition sessions was performed on 20 observations of
seven variables. Here, the observations correspond to the
four experimental groups on the five learning sessions,
and the variables are the experimental parameters de-
scribed above. The resulting 20  7 data matrix contains
the medians of the measured variables for each group
during each session (the four trials per mouse of each
learning session were averaged). As variables are mea-
sured in different units, they were scaled to unit variance
to enable a combined analysis. The result of the described
PCA approximates a decomposition of what is commonly
called between-group variance. A third kind of variability
coming from individuals within a group for a given session
can also be quantified. For this, 195 supplementary points
that correspond to the 39 individuals appearing five times
each were projected. The R package FactoMineR was
used (Lê et al., 2008). Separately, a similar PCA was done
for the three reversal sessions.
Our analysis can be considered a discriminant analysis
in the sense that the PCA is performed for groups and
individuals are projected only after the PCA is performed.
However, we use group medians instead of the commonly
applied group means weighted by group sizes, leading to
two differences: first, between-group variance is defined
as variance between group medians; second, the overall
barycenter no longer coincides with the group barycenter
(our origin), and thus the total variance obtained by sum-
ming squared distances of all individuals from the origin
as applied in Catuara-Solarz et al. (2015) overestimates
the true variance by a small amount (i.e. by the squared
distance of the barycenter from the origin). To comply
with the original definition (Greenacre, 2010, chapter 11)
of between-group variance when decomposing total vari-
ance, the overall barycenter instead of the origin can be
used as the reference point, and weighted group means
obtained from the supplementary points can be used to
calculate the between-group variance instead. We found
that the difference between the two approaches is on the
order of a few percentage points only.
To validate the stability of the PCA, we used a jackknif-
ing procedure: each individual is subtracted from the
analysis, the resulting modified group median is used to
perform a new PCA, and the angle between the new first
principal component (PC1) and PC2 with respect to the
original principal axes is computed. The procedure
showed that both axes remain very stable, with PC1
attaining maximum angles around 1 degree, suggesting a
minor influence of the small number of experimental
groups on the outcome of the analysis (data not shown).
Density plots were obtained using the statdensity_2d
function from the ggplot2 R package (Wickham, 2009;
RRID:SCR_014601) with the parameters: n  100, h  4,
and bins  6. to assess statistical significance of group
separation, we randomly reassigned individuals to exper-
imental groups to perform a permutation test (Sham and
Purcell, 2014) in which original numbers of individuals in
each group were kept. For this, learning differences were
evaluated using a t statistic involving PC1 pairwise group
comparisons based on supplementary points. All pairwise
comparisons were determined at each permutation. The
number of randomized PCAs was 10,000. Finally, to eval-
uate the change in within-group variances before and
after learning, we averaged squared distances of a
group’s supplementary points from their barycenter using
coordinates from all seven principal axes.
Novel object recognition
Differences in the discrimination index among experi-
mental groups were tested using one-way ANOVA. Tukey
multiple comparisons for parametric models were used to
address post hoc comparisons using the multtest R pack-
age and the glht function (Hand and Taylor, 1987; Dick-
haus, 2012). To control the FDR caused by multiple post
hoc comparisons, the Benjamini–Hochberg method was
used (Benjamini and Hochberg, 1995).
Dendritic spine density and excitatory (VGLUT1) and
inhibitory (VGAT) synaptic puncta
For analysis of the differences among the experimental
groups in dendritic spine densities and number, size, and
percentage of area occupied by synaptic puncta of
VGLUT1 and VGAT, we used linear mixed models, which
included experimental group as a factor and mouse as a
random effect to account for the repeated measures per
mouse. The F test was used to evaluate the global hy-
pothesis that there was no association between the re-
sponse variables and the groups. Whenever this
hypothesis was rejected, post hoc tests for the following
contrasts of interest were applied: WT versus TS; TS
versus TS EE-EGCG, and WT versus WT-EE-EGCG. The
analyses were performed using R packages nlme (Pin-
heiro et al., 2016) and multcomp (Hothorn et al., 2008) for
the fit of the linear mixed models and the multiple tests,
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respectively. Statistical significance was set at 0.05. The
significance levels for the three contrasts of interest were
adjusted to guarantee a family-wise error rate of 0.05.
Results
Effects of EE-EGCG treatment on
corticohippocampal-dependent learning and memory
impairment in Ts65Dn mice
To evaluate the effect of EE-EGCG treatment, we com-
pared the behavioral performance of WT and Ts65Dn
mice treated with EE-EGCG with their untreated counter-
parts in the MWM. During the acquisition sessions, there
were statistical differences among all groups in escape
latency, distance to the target [as shown by both the
Gallagher index (mean distance to the platform) and the
Gallagher (accumulated) distance to the platform], and
thigmotactic behavior, (percentage of time spent close to
the periphery) the percentage of time spent close to the
periphery of the pool (Table 1).
We detected learning defects in Ts65Dn mice com-
pared with WT (Fig. 1A) as shown by the higher escape
latency across sessions (Fig. 1B; Table 1), increased Gal-
lagher distance and index (Fig. 1A, C; Table 1), and typical
increase in thigmotactic behavior (Fig. 1A, D; Table 1).
EE-EGCG–treated Ts65Dn mice showed improved
learning performance during the acquisition sessions (Fig.
1A). In comparison to untreated Ts65Dn mice, EE-EGCG–
treated TS mice presented significantly reduced escape
latency (Fig. 1B; Table 1) and Gallagher distance and
index (Fig. 1A, C; Table 1) but no statistical differences in
thigmotactic behavior (Fig. 1A, D; Table 1). Conversely,
EE-EGCG–treated WT mice did not show differences
compared with untreated WT mice.
There were differences in swimming speed among the
groups; specifically, Ts65Dn mice had lower swimming
speeds than WTmice (data not shown; Table 1). However,
EE-EGCG did not promote significant changes in swim-
ming speed in Ts65Dn or WT with respect to the untreated
condition (data not shown; Table 1). This suggests that
the learning differences in EE-EGCG–treated Ts65Dn
mice are not mediated by changes in swimming speed.
To assess reference memory, a probe trial (removal
session) was performed 24 h after the final acquisition
day. In this session, there were no differences among
groups in the percentage of time spent in the target
quadrant, probably because of the high variability of the
data (data not shown). However, the latency to the first
entry to the platform area and the Gallagher distance,
which is a more precise performance measure (Maei et al.,
2009), showed significant differences among experimen-
tal groups (Fig. 1A, E, F; Table 1). Post hoc analysis
demonstrated higher values of Ts65Dn mice in the Gal-
Table 1. Single-variate MWM multiple post hoc comparisons with Benjamini–Hochberg correction.
95% confidence
interval
Figure Variable Phase Contrast Data structure Type of test
Estimated mean
difference SE Lower Higher p-value
Fig. 1B Latency ACQ Overall effect Continuous variable Tobit model 2(3)  42.24 0.001
Fig. 1B Latency ACQ TS_WT Continuous variable Tobit model 51.262 11.28 29.146 73.377 0.001
Fig. 1B Latency ACQ TS EE-EGCG_TS Continuous variable Tobit model –23.839 12.98 –49.280 1.602 0.028
Fig. 1B Latency ACQ TS EE-EGCG_WT Continuous variable Tobit model 27.423 11.40 5.066 49.780 0.005
Fig. 1C Gallagher distance ACQ Overall effect Continuous variable ANOVA repeated-measures F-test F  13.636 0.001
Fig. 1C Gallagher distance ACQ TS _WT Continuous variable ANOVA repeated-measures F-test 1903.3 397.6 1124 2682.6 0.001
Fig. 1C Gallagher distance ACQ TS EE-EGCG_TS Continuous variable ANOVA repeated-measures F-test –896.3 427.9 –1734.9 –57.6 0.043
Not shown Gallagher index ACQ Overall effect Continuous variable ANOVA repeated-measures F-test F  10.226 0.001
Not shown Gallagher index ACQ TS _WT Continuous variable ANOVA repeated-measures F-test 17.217 3.981 9.41424 25.01976 0.001
Not shown Gallagher index ACQ TS EE-EGCG _TS Continuous variable ANOVA repeated-measures F-test –8.903 4.284 –17.2996 –0.50636 0.045
Fig. 1D Thigmotaxis ACQ Overall effect Continuous variable ANOVA repeated-measures F-test F  9.22 0.001
Fig. 1D Thigmotaxis ACQ TS_WT Continuous variable ANOVA repeated-measures F-test 21.172 5.629 10.13916 32.20484 0.001
Fig. 1D Thigmotaxis ACQ TS EE-EGCG _TS Continuous variable ANOVA repeated-measures F-test –11.374 6.057 –23.2457 0.49772 0.09
Not shown Speed ACQ Overall effect Continuous variable ANOVA repeated-measures F-test F  4.883 0.006
Not shown Speed ACQ TS_WT Continuous variable ANOVA repeated-measures F-test –4.547 1.354 –7.20084 –1.89316 0.004
Not shown Speed ACQ TS_TS EE-EGCG Continuous variable ANOVA repeated-measures F-test 1.725 1.457 –1.13072 4.58072 0.28
Not shown Speed ACQ WT EE-EGCG _WT Continuous variable ANOVA repeated-measures F-test –0.485 1.216 –2.86836 1.89836 0.69
Fig. 1E Latency first entry REM TS_WT Continuous variable One-way ANOVA 25.284 7.295 10.9858 39.5822 0.004
Fig. 1E Latency first entry REM TS EE-EGCG _TS Continuous variable One-way ANOVA –16.075 7.850 –31.461 –0.689 0.096
Fig. 1F Latency first entry REM Overall effect Continuous variable One-way ANOVA F  6.159 0.002
Fig. 1F Gallagher index REM TS_WT Continuous variable One-way ANOVA 17.991 7.041 4.19064 31.79136 0.03
Fig. 1F Gallagher distance REM TS_WT Continuous variable One-way ANOVA 1272.4 455.5 –437.28 2165.18 0.025
Fig. 1F Gallagher index REM TS EE-EGCG _TS Continuous variable One-way ANOVA –11.944 7.577 –26.7949 2.90692 0.14
Fig. 1G Latency REV Overall effect Continuous variable Tobit model 2(3)  26.59 0.001
Fig. 1G Latency REV TS_WT Continuous variable Tobit model 35.093 9.16 17.124 53.063 0.001
Fig. 1G Latency REV TS EE-EGCG _TS Continuous variable Tobit model –14.865 9.28 –33.073 3.342 0.060
Fig. 1H Gallagher distance REV Overall effect Continuous variable ANOVA repeated-measures F-test F  7.694 0.001
Fig. 1H Gallagher distance REV TS_WT Continuous variable ANOVA repeated-measures F-test 2114.3 412 1306.78 2921.82 0.001
Fig. 1H Gallagher distance REV TS EE-EGCG _TS Continuous variable ANOVA repeated-measures F-test –869 443.3 –1737.87 –0.132 0.059
Not shown Gallagher index REV Overall effect Continuous variable ANOVA repeated-measures F-test F  11.714 0.001
Not shown Gallagher index REV TS_WT Continuous variable ANOVA repeated-measures F-test 20.8045 4.3102 12.35651 29.25249 0.001
Not shown Gallagher index REV TS EE-EGCG _TS Continuous variable ANOVA repeated-measures F-test –6.3488 4.638 –15.4393 2.74168 0.2
Fig. 1H Thigmotaxis REV Overall effect Continuous variable ANOVA repeated-measures F-test F  10.105 0.001
Fig. 1H Thigmotaxis REV TS_WT Continuous variable ANOVA repeated-measures F-test 21.393 6.268 9.10772 33.67828 0.001
Fig. 1H Thigmotaxis REV TS EE-EGCG _TS Continuous variable ANOVA repeated-measures F-test –9.867 6.745 –23.0872 3.3532 0.14
Not shown Speed REV Overall effect Continuous variable ANOVA repeated-measures F-test F  2.607 0.067
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Figure 1. EE–EGCG treatment effects on young Ts65Dn mice deficits in spatial learning, reference memory and cognitive
flexibility. A, Heat map representing the accumulated swimming trajectories of mice from the different experimental groups across
acquisition, removal, and reversal sessions in the MWM. Periphery and center zones are depicted at upper left. Color code is
represented on the right, with red corresponding to the most visited zones and black to less visited or nonvisited zones. Learning
curves are represented in latency (s) to reach the escape platform (B), Gallagher distance (accumulated distance to the goal in cm;
C), and thigmotaxis (percentage of time spent on the periphery; D) during the acquisition sessions. E,F, Boxplots of the distribution
of latency to the first entry to the platform area and the Gallagher distance of the four experimental groups in the removal session.
Dots indicate the values of each individual mouse. Reversal learning curves are represented in latency (s; G), Gallagher distance (H),
and thigmotaxis (I). A1-5, acquisition sessions 1–5; R1-3, reversal sessions 1–3 with four trials per day; REM, removal session. Data
in B, C, D, F, G, and H are mean SEM. Data in B and F were analyzed by a censored model, which considered 60 s as the maximum
trial duration. Data in C, D,G, and Hwere analyzed with ANOVA repeated measures, and data in Ewere analyzed by one-way ANOVA.
In all cases, Tukey multiple post hoc comparisons corrected with Benjamini–Hochberg were used. Even if all groups were considered
for multiple comparisons, the figure reports only statistically significant differences of the following relevant contrasts of interest: WT
versus TS; TS versus TS EE-EGCG; WT versus TS EE-EGCG. p  0.05, p  0.01, p  0.001.
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lagher distance and the latency to the first entry com-
pared with WT mice (Fig. 1A, E, F; Table 1), indicating
poorer reference memory. The mean difference in these
parameters between EE-EGCG–treated and untreated
Ts65Dn mice was fairly large; however, it did not reach
statistical significance, possibly because of high variabil-
ity of the data (Fig. 1A, E, F; Table 1).
In the reversal sessions, we detected statistical differ-
ences among the experimental groups in escape latency,
Gallagher distance and index, and thigmotaxis (Table 1).
Whereas untreated WT mice efficiently shifted their
search to the new platform position (Fig. 1A), Ts65Dn
mice had increased escape latency (Fig. 1G; Table 1),
increased Gallagher distance and index (Fig. 1A, H;
Table 1), and increased thigmotaxis across the three re-
versal learning sessions (Fig. 1A, I; Table 1), compared
with WT mice. During reversal, there was no significant
reduction in thigmotaxis, suggesting that this variable was
not associated with reversal learning.
EE-EGCG–treated Ts65Dn mice showed a fairly large
(although not statistically significant) reduction in the la-
tency to reach the new platform position compared with
untreated Ts65Dn mice (Fig. 1A, G; Table 1). There were
no significant differences between EE-EGCG–treated and
untreated Ts65Dn mice in Gallagher distance or index
(Fig. 1A, H; Table 1) or thigmotaxis (Fig. 1A, I; Table 1).
EE-EGCG–treated and untreated WT mice showed no
significant differences in the latency to reach the new
platform position, the Gallagher distance or index, or
thigmotaxis. During the reversal sessions, there were no
statistical differences in swimming speed among the ex-
perimental groups (not shown; Table 1).
Multidimensional analysis of learning using PCA
PCA enabled placement of the experimental groups in a
low-dimensional coordinate system built from variables
taken during the MWM experiment. A group’s progression
along the acquisition sessions became apparent in its
resulting 5-day trajectory (Fig. 2A). We obtained a PC1
that explained 84% of the between-group variance and
was mainly composed of learning-related variables (i.e.,
escape latency, Gallagher index, percentage of time
spent in periphery, Whishaw index, distance traveled,
percentage of time spent in target quadrant; Figs. 2B, C).
Swimming speed also contributed to PC1, but to a lesser
extent. Efficient learning behaviors (short distances to
target, low escape latencies, high percentages of time in
the target quadrant, etc.) correspond to large values of
PC1 (Fig. 2B), and thus PC1 can be interpreted as a
quantification of learning. In contrast, PC2 explained 11%
of between-group variance and was mainly composed of
swimming speed (Figs. 2B, D). This component of speed
is unrelated to learning, since PC2 is orthogonal to the
learning-related PC1. It thus seems to reflect motor per-
formance rather than determination to reach the target
quickly. Swimming speed is thus decomposed in a
learning-dependent component (PC1) and a learning-
independent component (PC2). Learning-related vari-
ables contributed to a much lesser extent to PC2.
Because a group trajectory represents a group’s overall
learning through its progression along PC1, the trajectory
representation allows for effective comparisons between
group performances. Untreated Ts65Dn mice showed a
trajectory reaching a maximum value of PC1 that corre-
sponds to initial PC1 values of the untreated WT trajec-
tory, revealing poor learning. On the other hand, the EE-
EGCG–treated Ts65Dn trajectory attained more advanced
maximum values of PC1.
Additionally, we determined individual variation within
the groups by mapping the position of each individual on
each acquisition day on the PCA plot. As shown in the
density plots of sessions 1 and 5 in Fig. 2E, there is
substantial individual variation across learning sessions in
all the experimental groups. In fact, overall group differ-
ences explain less than half of the total variance. Within-
group variance, however, differs between experimental
groups. Whereas WT mice generally show higher variabil-
ity than Ts65Dn mice, the treatment roughly doubles vari-
ance for both genotypes in the first learning session.
Interestingly, learning increases variability in all groups.
This effect is stronger for untreated groups, so treated
and untreated groups show similar variability in the final
learning session. We summarize within-group variances
of the first and last acquisition sessions in Table 2.
To assess the statistical significance of differences in
learning, we performed a permutation test involving a t
statistic based on PC1. Untreated Ts65Dn mice had sig-
nificantly lower PC1 values in comparison to WT mice in
the first learning session (Fig. 2F; Table 3). EE-EGCG–
treated Ts65Dn mice had higher PC1 than untreated
Ts65Dn mice (Fig. 2F; Table 3); at this stage, the differ-
ence could be associated with procedural learning and
was not significantly different from untreated WT (Fig. 2F;
Table 3). At the end of the learning period (session 5),
untreated Ts65Dn mice still had significantly lower PC1
values in comparison to WT mice (Fig. 2F; Table 3). EE-
EGCG–treated Ts65Dn mice exhibited higher PC1 than
untreated Ts65Dn mice, although they showed signifi-
cantly lower PC1 values than untreated WT mice (Fig. 2F;
Table 3). On the other hand, EE-EGCG treatment did not
significantly change learning outcomes of WT mice in
either the first or the last session.
Similarly, group trajectories comprising three time
points each were obtained for the reversal sessions (Fig.
3A). Here, PC1 explained 84% of the between-group
variance and, as in the acquisition sessions, was domi-
nated by learning-related variables (Fig. 3B, C). PC2,
which explained 12% of the between-group variance,
showed again a strong contribution of swimming speed.
The main contribution here, however, turned out to be
from thigmotaxis (Fig. 3B, D). Interestingly, these two
variables fall on a line separating the groups along an
efficiency gradient from strong thigmotaxis and low speed
to no thigmotaxis and high speed in the order TS, TS-EE-
EGCG, WT, and WT-EE-EGCG (Fig. 3A, B). Again, there
was an increased within-group variability associated with
the learning process in all groups (Fig. 3E; Table 2).
According to the permutation tests, untreated Ts65Dn
mice showed significantly lower PC1 than untreated WT
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Figure 2. Supervised PCA of the experimental groups during the acquisition sessions revealed that EE-EGCG treatment improves
global learning in Ts65Dn mice. A, Trajectories connect group performance (medians) along the five learning sessions (labeled with
respective numbers) in the space defined by PC1 and PC2, which consist of linear combinations of the original variables. B, Variable
directionality in the PCA space. Arrows represent the direction with respect to PC1 and PC2. Variables reaching the unit circle belong
to variables that are well represented by the two principal components. Contribution of variables to PC1 (C) and PC2 (D) in percent.
PC1 receives a similar contribution from all classic variables used to assess learning and can thus be understood as a composite
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mice (Fig. 3F; Table 2). EE-EGCG–treated Ts65Dn mice
had significantly higher PC1 than untreated Ts65Dn mice,
although they still showed significantly lower PC1 than
WT mice (Fig. 3F; Table 2). In WT mice, EE-EGCG treat-
ment did not modify cognitive flexibility outcomes in the
first or the last session.
Effects of EE-EGCG treatment on recognition
deficits in Ts65Dn mice
To assess the impact of the treatment on a less stress-
ful learning task, we conducted a novel object recognition
test. The performance of this test depends on the func-
tionality of the entorhinal and perirhinal cortices and the
hippocampus (Brown and Aggleton, 2001).
In this test, Ts65Dn mice showed no deficit in their DI in
comparison to WT mice, although a slight tendency to
impairment was detected (p  0.08; Fig. 4; Table 4).
EE-EGCG–treated Ts65Dn mice had an increase in their
DI with respect to their untreated counterparts (Fig. 4;
Table 4) and scored at similar levels to WT mice (Fig. 4;
Table 4). Conversely, EE-EGCG–treated WT mice showed
a poorer performance than untreated WT mice (Fig. 4;
Table 4).
Effects of EE-EGCG treatment on dendritic spine
density in Ts65Dn hippocampus
Ts65Dn mice showed a significant reduction of den-
dritic spine density in the CA1 (Fig. 5A; Table 5) and DG
(Fig. 5B; Table 5) hippocampal subregions. EE-EGCG–
treated Ts65Dn mice did not show statistically significant
differences in DG dendritic spine density compared with
untreated Ts65Dn or WT mice (Fig. 5B). Conversely, EE-
EGCG–treated Ts65Dn mice had increased dendritic
spine density in CA1 in comparison to untreated Ts65Dn
mice (Fig. 5A; Table 5), and EE-EGCG–treated WT mice
showed reduced CA1 dendritic spine density in compar-
ison to untreated WT mice (Fig. 5A; Table 5).
continued
learning variable. E, Boxplots of PC1 distribution for each experimental group on sessions 1 and 5 of the acquisition phase. Box plot
horizontal lines, group median; box edges, 25th and 75th percentiles; whiskers, minimum and maximum values to a maximum of 1.5
times the interquartile distance from the box. More extreme values are individually plotted. Only relevant comparisons are reported
in the figure for the sake of clarity (WT versus TS; TS versus TS EE-EGCG; WT versus TS EE-EGCG), even if all groups were
considered for the permutation test. p 0.05, p 0.01,p 0.001. The benefits of the EE-EGCG treatment on Ts65Dn learning
explain the displacement of this group toward more positive values along the PC1.
Table 2. Multivariate within-group variances (sum over
squared distances from group barycenter divided by group
size, scaled by number of variables) before and after acqui-
sition, and reversal sessions.
Figure Session WT WT-EE-EGCG TS TS-EE-EGCG
Fig. 2E ACQ1 0.42 0.89 0.24 0.53
Fig. 2E ACQ5 1.62 1.55 0.87 0.95
Fig. 3E REV1 1.52 1.12 0.56 1.22
Fig. 3E REV3 2.68 1.84 1.42 2.26
Table 3. Permutation-test results of learning-related composite measure PC1.
Figure Variable Phase Contrast Pseudo-t p-value
Fig. 2E PC1 ACQ1 TS_WT 3.67 0.001
Fig. 2E PC1 ACQ1 TS_WT EE-EGCG 3.57 0.001
Fig. 2E PC1 ACQ1 TS_TS EE-EGCG 3.05 0.004
Fig. 2E PC1 ACQ1 TS EE-EGCG_WT 0.28 0.39
Fig. 2E PC1 ACQ1 TS EE-EGCG_WT EE-EGCG 0.54 0.71
Fig. 2E PC1 ACQ1 WT_WT EE-EGCG 0.8 0.89
Fig. 2E PC1 ACQ5 TS_WT 6.81 0.001
Fig. 2E PC1 ACQ5 TS_WT EE-EGCG 6.72 0.001
Fig. 2E PC1 ACQ5 TS_TS EE-EGCG 1.85 0.045
Fig. 2E PC1 ACQ5 TS EE-EGCG_WT 5.2 9.99
Fig. 2E PC1 ACQ5 TS EE-EGCG_WT EE-EGCG 5.06 0.001
Fig. 2E PC1 ACQ5 WT_WT EE-EGCG 0.27 0.39
Fig. 3E PC1 REV1 TS_WT 4.60 0.001
Fig. 3E PC1 REV1 TS_WT EE-EGCG 5.60 0.001
Fig. 3E PC1 REV1 TS_TS EE-EGCG 2.59 0.01
Fig. 3E PC1 REV1 TS EE-EGCG_WT 2.44 0.01
Fig. 3E PC1 REV1 TS EE-EGCG_WT EE-EGCG 3.07 0.005
Fig. 3E PC1 REV1 WT_WT EE-EGCG 0.23 0.58
Fig. 3E PC1 REV3 TS_WT 5.17 0.001
Fig. 3E PC1 REV3 TS_WT EE-EGCG 6.19 0.001
Fig. 3E PC1 REV3 TS_TS EE-EGCG 2.32 0.02
Fig. 3E PC1 REV3 TS EE-EGCG_WT 2.66 0.01
Fig. 3E PC1 REV3 TS EE-EGCG_WT EE-EGCG 3.21 0.004
Fig. 3E PC1 REV3 WT_WT EE-EGCG 0.21 0.58
New Research 10 of 18
September/October 2016, 3(5) e0103-16.2016 eNeuro.org
Figure 3. Supervised PCA of the experimental groups during the reversal sessions revealed poorer cognitive flexibility of untreated
Ts65Dn mice. A, Trajectories of medians along the reversal session (accordingly labeled) on the space formed by PC1 and PC2. B,
Variable directions on the PCA space defined by PC1 and PC2. Variables reaching the unit circle belong to variables that are well
represented by the two principal components. Bar plots represent the contribution of variables to PC1 (C) and PC2 (D) in percent. E,
Box plots of PC1 distribution for each experimental group on sessions 1 and 3 of the reversal phase. Box plot horizontal lines, group
median; box edges, 25th and 75th percentiles; whiskers, minimum and maximum values to a maximum of 1.5 times the interquartile
distance from the box. More extreme values are individually plotted. Only relevant comparisons are reported in the figure for the sake
of clarity (WT versus TS; TS versus TS EE-EGCG; WT versus TS EE-EGCG), even if all groups were considered for the permutation
test. p 0.05, p 0.01,p 0.001. The shift of mouse groups toward positive values of PC1 represents the increased cognitive
flexibility of the groups, with EE-EGCG–treated Ts65Dn mice attaining higher values than their untreated counterparts.
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Effects of EE-EGCG treatment on hippocampal
excitatory and inhibitory synaptic puncta in Ts65Dn
mice
In DG, Ts65Dn mice showed increased VGLUT1 puncta
density (data not shown; Table 6) of reduced size (data not
shown; Table 6), and no differences in the number or size of
VGAT puncta compared with WT mice. This resulted in an
increased VGLUT1/VGAT density ratio (Fig. 6A; Table 6).
Because the increase in the number of VGLUT1 puncta was
compensated by a reduction in size, Ts65Dn mice showed
no difference in the VGLUT1/VGAT percentage of area oc-
cupied compared with WT mice (Fig. 6B; Table 6).
In CA1, Ts65Dn mice also showed significantly in-
creased density of VGLUT1 puncta of reduced size com-
pared with WT mice (data not shown; Table 6). As in DG,
Ts65Dn mice presented no differences in VGAT density
puncta in CA1, but in this region, VGAT puncta were
enlarged (data not shown; Table 6). This resulted in an
increased ratio of VGLUT1/VGAT puncta density (Fig. 6C;
Table 6), and a reduced VGLUT1/VGAT percentage of
area occupied (Fig. 6D; Table 6).
Compared with untreated conditions, EE-EGCG–
treated Ts65Dn mice exhibited a significant reduction in
the density of VGLUT1 puncta in DG (data not shown;
Table 6) but not in CA1. VGLUT1 puncta were significantly
enlarged in DG (data not shown; Table 6) but not in CA1.
There were no significant differences in VGAT puncta
number or size between EE-EGCG–treated and untreated
Ts65Dn mice in DG or CA1. As a result, EE-EGCG–treated
Ts65Dn mice showed a reduction in the ratio of VGLUT1/
VGAT density in both DG (Fig. 6A; Table 6) and CA1 (Fig.
6C; Table 6), leading to values that were similar to those of
WT mice. On the other hand, EE-EGCG–treated WT mice
also showed a trend toward an enlargement of VGAT
puncta size in CA1 (data not shown; Table 6), leading to a
decreased VGLUT1/VGAT percentage of area occupied
(Fig. 6D; Table 6) in comparison to untreated WT mice.
Discussion
In the present study, combined EE-EGCG treatment
significantly increased spine density in CA1, normalized
excitatory and inhibitory synaptic markers in CA1 and DG,
and improved performance in a corticohippocampal-
dependent learning task in young Ts65Dn mice.
In line with previous studies, we detected poor learning
strategies and hippocampal-dependent learning and
memory performance in the MWM in young Ts65Dn mice
(Escorihuela et al., 1995; Reeves et al., 1995). In Ts65Dn
Figure 4. Effect of treatment on DI in the novel object recognition test. Left, diagram of the apparatus used for the novel object
recognition test. Right, boxplots of the distribution of the DI (%) among the experimental groups. Dots, DI measure from each
individual mouse; dashed lines, group means; continuous lines, group medians. Data were analyzed using one-way ANOVA and
Tukey multiple post hoc comparisons corrected with Benjamini–Hochberg. Even if all groups were considered for multiple compar-
isons, the figure reports only statistically significant differences of the following relevant contrasts of interest: WT versus TS; TS versus
TS EE-EGCG; WT versus TS EE-EGCG. p  0.05, p  0.01. Ts65Dn mice show a trend toward a reduction in DI (p  0.08).
EE-EGCG treatment improves DI score in Ts65Dn mice but worsens performance in WT mice.
Table 4. Novel object recognition test (discrimination index).
95% confidence
interval
Figure Contrast Data structure Type of test
Estimated mean
difference Lower Higher p-value
Fig. 4 TS _WT Continuous variable ANOVA –21.728 –42.94 –0.511 0.083
Fig. 4 TS EE-EGCG_TS Continuous variable ANOVA 27.224 5.311 49.136 0.044
Fig. 4 TS EE-EGCG _WT Continuous variable ANOVA 5.496 –15.721 26.713 0.616
Fig. 4 WT EE-EGCG_WT Continuous variable ANOVA –42.928 –64.145 –21.711 0.001
New Research 12 of 18
September/October 2016, 3(5) e0103-16.2016 eNeuro.org
mice, but not WT mice, EE-EGCG treatment improved
performance in the MWM, reducing escape latency and
Gallagher index and distance during the learning ses-
sions. PCA confirmed that untreated Ts65Dn showed
inefficient learning progress over acquisition sessions,
reaching maximum values of PC1, a global learning vari-
able, similar to initial WT values. EE-EGCG–treated
Ts65Dn mice improved on global learning measures. They
reached more advanced maximum PC1 values than un-
treated Ts65Dn mice, suggesting a modification in
learning-related behavior as previously reported in
middle-age Ts65Dn mice (Catuara-Solarz et al., 2015).
Ts65Dn mice also exhibited poor reference memory, as
indicated by a significantly increased Gallagher index and
distance and latency to the first entry to the platform area
in the probe trial. However, no genotype effects were
detected in other variables, such as time spent in the
target quadrant or latency to first entry to target area,
probably because of the high variability of the data. Ad-
ditionally, Ts65Dn mice presented a deficit in cognitive
Figure 5. Ts65Dn mice show a reduction in dendritic spine density in DG and CA1, and EE-EGCG treatment ameliorates this
deficit in CA1. Left, dorsal hippocampal region of a Golgi preparation illustrating dendrites from CA1 and DG subregions; scale
bar represents 10 m. A,B, Boxplots of the distribution of dendritic spine density (spines per micrometer) in DG and CA1 among
the experimental groups. Dots, repeated values from individual mice (two to three dendrites per slice, three dorsal hippocampal
slices per brain, five to six mice per experimental group); dashed lines, group means; continuous lines, group medians. Data
were analyzed with a linear mixed model, which included experimental group as a factor and mouse as a random effect. F test
was used to test the global hypothesis. Post hoc tests were applied for the following contrasts of interest: WT versus TS; TS
versus TS EE-EGCG; WT versus WT-EE-EGCG. p  0.05, p  0.001. Ts65Dn mice show a significant reduction in spine
density in both DG and CA1. EE-EGCG treatment increases dendritic spine density in Ts65Dn CA1 and decreases this parameter
in WT.
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flexibility, as shown by the inefficient performance during
the reversal sessions (executive function).
Single-variate analysis of different parameters between
EE-EGCG–treated and untreated Ts65Dn mice did not
reach statistical significance at reference memory and
reversal sessions. However, a significant enhancement in
cognitive flexibility was shown by multivariate analysis of
the reversal sessions. In middle-age Ts65Dn mice, EE-
EGCG treatment improved learning and reference mem-
ory, but not cognitive flexibility (Catuara-Solarz et al.,
2015). This suggests that EE-EGCG treatment effects
depend on age and cognitive domain, possibly because
of differential effects on different underlying brain regions
and functions at different ages. EE-EGCG–treated WT
mice did not show significant differences, possibly be-
cause of a ceiling effect.
MWM is a learning paradigm based on the stressful and
aversive stimuli of the water pool, which triggers in-
creases in plasma corticosterone, leading to a motiva-
tional state in the mice to learn the spatial configuration of
the cues to escape (Harrison et al., 2009). Previous stud-
ies have shown that EGCG exerts an anxiolytic effect on
different behavioral anxiety tests such as the forced
swimming test, elevated plus maze, passive avoidance
test, and tail suspension test (Dias et al., 2012). It could
thus be speculated that the potential anxiolytic effects of
EGCG would contribute to the learning improvement we
found in the MWM. However, a number of facts suggest
that the learning improvements found in treated Ts65Dn
mice are not mainly contributed by the anxiolytic effect of
EGCG. Ts65Dn mice have reduced levels of anxiety-like
behavior in the elevated plus maze (Coussons-Read,
1996; Demas, 1996; Escorihuela, 1998; Shichiri, 2011),
suggesting that the learning deficits shown by Ts65Dn in
the MWM are not associated with anxiety. Thus a poten-
tial anxiolytic effect of EGCG would not eventually lead to
significant learning improvement. Additionally, in the case
of a potential MWM improvement associated with the
anxiolytic effect of EGCG, we should be able to observe it
in the control group that is subjected to the same anx-
iogenic scenario. However, in our study, the WT group did
not benefit from the combined EE-EGCG treatment.
Even so, we also addressed the effects of the combined
EE-EGCG treatment in a less stressful learning test, the
novel object recognition test. The performance of this test
depends on the functionality of the entorhinal and perirhi-
nal cortices and the hippocampus (Brown and Aggleton,
2001; Brown et al., 2010). In this test, trisomic mice
presented no significant deficit in their DI in comparison to
WT mice, similar to some previous reports (Hyde and
Crnic, 2002), although a slight tendency to impairment
was detected that is in line with data from Fernandez et al.
(2007). EE-EGCG–treated Ts65Dn mice presented an im-
provement in DI with respect to untreated counterparts
and scored at similar levels to WT mice. On the other
hand, EE-EGCG–treated WT mice showed a poorer per-
formance than untreated WT mice, suggesting a possible
deleterious effect of EGCG.
Table 5. Dendritic spine density.
95% confidence
interval
Figure Region Contrast Data structure Type of test
Estimated mean
difference Lower Higher p-value
Fig. 5A DG TS _WT Continuous variable Mixed-model F-test –0.192 –0.383 –0.002 0.048
Fig. 5B CA1 TS _WT Continuous variable Mixed-model F-test –0.175 –0.282 –0.069 0.001
Fig. 5B CA1 TS EE-EGCG_TS Continuous variable Mixed-model F-test 0.105 0.001 0.209 0.047
Fig. 5B CA1 WT EE-EGCG_WT Continuous variable Mixed-model F-test –0.129 –0.234 –0.025 0.01
Table 6. VGLUT1 and VGAT synaptic puncta.
95% confidence
interval
Figure Variable Region Contrast Data structure Type of test
Estimated mean
difference Lower Higher p-value
Not shown VGLUT1 puncta density DG TS _WT Continuous variable Mixed-model F-test 0.077 0.018 0.136 0.006
Not shown VGLUT1 puncta size DG TS _WT Continuous variable Mixed-model F-test –0.06 –0.098 –0.022 0.001
Fig. 6A VGLUT1/VGAT puncta density DG TS _WT Continuous variable Mixed-model F-test 0.308 0.151 0.465 0.001
Fig. 6B VGLUT1/VGAT % of area DG TS _WT Continuous variable Mixed-model F-test 0.077 –0.03 0.183 0.222
Not shown VGLUT1puncta density DG TS EE-EGCG_TS Continuous variable Mixed-model F-test –0.073 –0.132 –0.014 0.01
Not shown VGLUT1 puncta size DG TS EE-EGCG_TS Continuous variable Mixed-model F-test 0.06 0.022 0.098 0.001
Fig. 6A VGLUT1/VGAT puncta density DG TS EE-EGCG_TS Continuous variable Mixed-model F-test –0.294 –0.452 –0.137 0.001
Not shown VGLUT1 puncta density CA1 TS _WT Continuous variable Mixed-model F-test 0.071 0.008 0.134 0.022
Not shown VGLUT1 puncta size CA1 TS _WT Continuous variable Mixed-model F-test –0.093 –0.145 –0.041 0.043
Not shown VGAT puncta size CA1 TS _WT Continuous variable Mixed-model F-test 0.054 0.001 0.106 0.043
Fig. 6C VGLUT1/VGAT puncta density CA1 TS _WT Continuous variable Mixed-model F-test 0.295 0.098 0.493 0.001
Fig. 6D VGLUT1/VGAT % of area CA1 TS _WT Continuous variable Mixed-model F-test –0.145 –0.275 –0.016 0.023
Fig. 6C VGLUT1/VGAT puncta density CA1 TS EE-EGCG_TS Continuous variable Mixed-model F-test –0.245 –0.442 –0.047 0.01
Not shown VGAT puncta size CA1 WT EE-EGCG_WT Continuous variable Mixed-model F-test 0.049 –0.003 0.102 0.07
Fig. 6D VGLUT1/VGAT % of area CA1 WT EE-EGCG_WT Continuous variable Mixed-model F-test –0.137 –0.267 –0.007 0.035
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Along with learning improvement, EE-EGCG–treated
mice showed significant neuromorphologic changes in
the hippocampus. Consistent with previous reports in DS
(Ferrer and Gullotta, 1990) and Ts65Dn mice (Belichenko
et al., 2004), we observed a reduction in dendritic spine
density in outer molecular layer dendrites from granule
cells of the DG, and in apical dendrites of pyramidal
neurons of CA1 in Ts65Dn mice. Combined treatment
with EE-EGCG partially rescued the dendritic spine den-
sity deficit in CA1, but not in the DG of Ts65Dn mice. A
reduction of Dyrk1A kinase activity (Bain et al., 2003;
Golabek et al., 2011; Pons-Espinal et al., 2013), but also
other signaling pathways that are modified by both EE
and EGCG, such as increased CREB and Akt phosphor-
ylation (Jia et al., 2013; Ramírez-Rodríguez et al., 2014;
Ortiz-López et al., 2016) or increases in BDNF expression
(Young et al., 1999; Li et al., 2009a, 2009b), could con-
tribute to these neuroplasticity changes.
We also explored the effects of EE-EGCG treatment on
E/I balance, using excitatory (VGLUT1) and inhibitory
(VGAT) synaptic vesicle markers. In Ts65Dn DG, VGLUT1
puncta were more abundant but smaller, with no changes
in the percentage of area occupied, whereas VGAT
puncta showed no differences compared with WT litter-
mates. In CA1, Ts65Dn mice showed the same pheno-
type, VGLUT1 puncta being more abundant and smaller;
however, in this region, VGAT puncta were enlarged,
leading to an increased VGLUT1/VGAT ratio but a reduc-
tion of VGLUT1/VGAT percentage of area occupied. That
in both DG and CA1 VGLUT1 puncta were more abundant
Figure 6. EE-EGCG effects on VGLUT1/VGAT puncta in DG and CA1. Box plots of the distribution of VGLUT1/VGAT ratios of different
puncta density and percentage of area among the experimental groups at DG and CA1. A, C, VGLUT1/VGAT ratio of puncta density
(puncta per square micrometer). B, D, VGLUT1/VGAT ratio of percentage of area occupied. Dots, repeated values from individual
mice; dashed lines, group means; continuous lines, group medians. Data were analyzed with a linear mixed model, which included
experimental group as a factor and mouse as a random effect. F test was used to test the global hypothesis. Post hoc tests were
applied for the following contrasts of interest: WT versus TS; TS versus TS EE-EGCG; WT versus WT-EE-EGCG. p  0.05, p 
0.01, p  0.001.
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and smaller in Ts65Dn could affect the probability or
efficiency in neurotransmitter release (Harris and Sultan,
1995; Bozdagi et al., 2000; Antonova et al., 2001; Bamji
et al., 2006; Bourne et al., 2013) and could also be related
to the previously reported enhanced GABAA and GABAB
evoked inhibitory postsynaptic currents in DG of 3- to
4-month-old male mice (Kleschevnikov et al., 2012) and
increased GABA release in the hippocampus of male and
female adult mice (Begenisic et al., 2011). Consistent with
our results, previous work showed no changes in density
of VGAT puncta nor density of inhibitory synapses using
electron microscopy in the DG of 3-month-old male mice,
although apposition length of symmetric (inhibitory) syn-
apses was larger (Belichenko et al., 2009). Additionally,
Kleschevnikov et al. (2012) found no differences in GAD67
optical density in DG, with only a trend toward reduction
in GAD67 in the outer molecular layer of 3- to 4-month-old
male mice. A recent study using Western blot showed a
reduction in the hippocampal expression of VGLUT1 and
no statistical difference in VGAT (Souchet et al., 2015).
Conversely, others have shown an increase in the per-
centage of area occupied by VGAT puncta and VGAT/
gephyrin puncta in DG of 4.5- to 5.5-month-old male mice
(Martinez-Cue et al., 2013). Differences in experimental
methods, hippocampal subregions, age, or sex could
account for these divergent results. On the other hand,
very little is known about how E/I is affected across
different brain regions or ages in Ts65Dn mice. Possibly,
the E/I imbalance could arise from alterations in excita-
tion, inhibition, or both and may be continuously changing
as a result of synaptic plasticity, leading to region-specific
dysfunction (Bartley et al., 2015).
Interestingly, EE-EGCG–treated Ts65Dn mice showed
normal density and size of VGLUT1 puncta, and as a
consequence, the balance of excitatory and inhibitory
puncta in DG and in CA1 was also in the normal ranges.
That the treatment restores the density and size of
VGLUT1 puncta is consistent with the treatment effect on
the density of dendritic spines. Excitatory synapses com-
prise a presynaptic terminal with abundant synaptic ves-
icles containing glutamate, in association with dendritic
spine heads acting as a postsynaptic element. Thus, our
results suggest that combined treatment with EE-EGCG
may increase excitatory synaptic connections.
These results are also consistent with the outcome of a
recent phase II clinical trial with DS individuals in which a
therapy combining cognitive training and EGCG normal-
ized neuronal network functionality, as measured by func-
tional MRI, and cortical excitability by transcranial
magnetic stimulation (de la Torre et al., 2016).
Conversely, in WT mice EE-EGCG treatment reduced
spine density in CA1, but not in the DG, and led to E/I
imbalance in CA1, without significant changes in the DG.
This deleterious effect could be explained by an overinhibi-
tion of Dyrk1A kinase activity in WT conditions, since it has
been shown that DYRK1A haploinsufficiency is associated
with neuroanatomical and neuroarchitectural defects in flies,
mice, and humans. Indeed, mutant flies with reduced
Dyrk1A expression present reductions in the volumes of the
adult optic lobes and central brain hemispheres (Tejedor
et al., 1995). Brains from Dyrk1A heterozygous mice are
30% smaller and have reduced size and weight in specific
brain regions, along with reduced neuronal density in the
superior colliculus and increased neuronal numbers in brain
regions such as somatosensory and motor cortices (Fotaki
et al., 2002), with significantly smaller and less complex
basal dendritic arbors and reduced dendritic spine densities
(Benavides-Piccione et al., 2005). In the hippocampus,
Dyrk1A heterozygous mice show a significant reduction in
hippocampal thickness, accompanied by decreases in cell
number in CA1, CA2, CA3, and DG (Arqué et al., 2008).
Humans with de novo heterozygous variants of DYRK1A
also have congenital microcephaly, structural brain abnor-
malities, and intellectual disability (Møller et al., 2008; Ji et al.,
2015).
Taken together, our results suggest that combined treat-
ment with EE and EGCG is a potent cognitive enhancing
intervention for DS. We demonstrated that EE-EGCG treat-
ment–derived cognitive improvements are associated with
neuromodulatory effects at the hippocampus that normalize
defects in dendritic spine density and E/I synaptic puncta
ratio. Overall results suggest that combined EE-EGCG treat-
ment has the capacity to simultaneously target several ab-
normal processes underlying intellectual disability in DS
which would be optimal for a disease-modifying intervention
in this clinical population.
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